Phenoxodiol - An isoflavone analog - Induces apoptosis in chemoresistant ovarian cancer cells

Oncogene

Volumn 22, Issue 17, 2003, Pages 2611-2620

  Kamsteeg, Marijke ^a   Rutherford, Thomas ^a   Sapi, Eva ^a   Hanczaruk, Bozena ^a   Shahabi, Shoreh ^a   Flick, Maryann ^a   Brown, David ^a,b   Mor, Gil ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Marshal Edwards Inc   (Australia)

Author keywords

Apoptosis; Fas; Ovarian cancer; Phenoxodiol; XIAP

Indexed keywords

CASPASE; CELL PROTEIN; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; GENISTEIN; ISOFLAVONE DERIVATIVE; PHENOXODIOL; PROTEIN KINASE B; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL DESTRUCTION; CARCINOGENESIS; CELL DEATH; CELL ISOLATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; FEMALE; GENE CONTROL; GENE FUNCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOPYRANS; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CASPASE 9; CASPASES; CELL LINE; DRUG RESISTANCE, NEOPLASM; FAS LIGAND PROTEIN; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOFLAVONES; MEMBRANE GLYCOPROTEINS; OVARIAN NEOPLASMS; PHENOLS; PROTEINS; SIGNAL TRANSDUCTION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

ANIMALIA; FALLOPIA;

EID: 0037854571     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206422     Document Type: Article

References (42)

1. Aschkenazi S, Straszewski S, Verwer KM, Foellmer H, Rutherford T and Mor G. (2002). Biol. Reprod., 66, 1853-1861.
2. Baldwin RL, Tran H and Karlan BY. (1999). Gynecol. Oncol., 74, 265-271.
3. Berchuck A, Elbendary A, Havrilesky L, Rodriguez GC and Bast Jr RC. (1994). J. Soc. Gynecol. Invest., 1, 181-190.
4. Constantinou A and Husband A. (2002). Anticancer Res., 22, 2581-2585.
5. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS and Reed JC. (1999). EMBO J., 18, 5242-5251.
6. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS and Reed JC. (1998). EMBO J., 17, 2215-2223.
7. Flick M, Rodov S, Kamsteeg M, Rutherford T, O'Malley D, Kacinski B and Mor G. (in preparation).
8. Green DR and Evan GI. (2002). Cancer Cell, 1, 19-30.
9. Green M, Clark J and Blayroy D. (1984). Semin. Oncol., 11, 209-226.
10. Gutierrez LS, Eliza M, Niven-Fairchild T, Naftolin F and Mor G. (1999). Breast Cancer Res. Treat., 54, 245-253.
11. Hanahan D and Weinberg RA. (2000). Cell, 100, 57-70.
12. Hughes Jr FM and Gorospe WC. (1991). Endocrinology, 129, 2415-2422.
13. Johnstone RW, Ruefli AA and Lowe SW. (2002). Cell, 108, 153-164.
14. Kim Y, Suh N, Sporn M and Reed JC. (2002). J. Biol. Chem., 277, 22320-22329.
15. Kirchhoff S, Muller WW, Krueger A, Schmitz I and Krammer PH. (2000). J. Immunol., 165, 6293-6300.
16. Krueger A, Schmitz I, Baumann S, Krammer PH and Kirchhoff S. (2001). J. Biol. Chem., 276, 20633-20640.
17. Lamartiniere CA, Murrill WB, Manzolillo PA, Zhang JX, Barnes S, Zhang X, Wei H and Brown NM. (1998). Proc. Soc. Exp. Biol. Med., 217, 358-364.
18. Lowe SW and Lin AW. (2000). Carcinogenesis, 21, 485-495.
19. Mor G, Munoz A, Redlinger Jr R, Silva I, Song J, Lim C and Kohen F. (2001). Am. J. Reprod. Immunol., 46, 298-307.
20. Mor G, Straszewski S and Kamsteeg M. (2002). Biochem. Pharmacol., 64, 1305-1315.
21. Mori T, Xu J, Mori E, Sato E, Saito S and Guo M. (1997). Hormone Res., 48, 11-19.
22. Muller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M, Friedman SL, Galle PR, Stremmel W, Oren M and Krammer PH. (1998). J. Exp. Med., 188, 2033-2045.
23. O'Dwyer PJ, Moyer JD, Suffness M, Harrison Jr SD, Cysyk RHTC and Plowman J. (1994). Cancer Res., 54, 724-729.
24. Panka DJ, Mano T, Suhara T, Walsh K and Mier JW. (2001). J. Biol. Chem., 276, 6893-6896.
25. Peter ME, Scaffidi C, Medema JP, Kischkel F and Krammer PH. (1999). Results Probl. Cell Differ., 23, 25-63.
26. Quirk SM, Cowan RG and Huber SH. (1997). Endocrinology, 138, 4558-4566.
27. Reed JC. (2002). Nat. Rev. Drug. Discov., 1, 111-121.
28. Rohn JL, Hueber AO, McCarthy NJ, Lyon D, Navarro P, Burgering BM and Evan GI. (1998). Oncogene, 17, 2811-2818.
29. Roughton SA, Lareu RR, Bittles AH and Dharmarajan AM. (1999). Biol. Reprod, 60, 797-804.
30. Salvesen GS and Duckett CS. (2002). Nat. Rev. Mol. Cell. Biol., 3, 401-410.
31. Sapi E, Brown W, Aschkenazi S, Tartaro K, Lim C, Munoz A, Kacinski B, Rutherford T and Mor G. (2002). J. Soc. Gynecol. Invest., 9, 243-250.
32. Scaffidi C, Schmitz I, Krammer PM and Peter ME. (1999). J. Biol. Chem., 274, 1541-1548.
33. Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW and Lowe SW. (1999). Science, 284, 156-159.
34. Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C and Lowe SW. (2001). Nature, 409, 207-211.
35. Song J, Rutherford T, Brown S and Mor G. (2002). Mol. Human Reprod., 8, 447-455.
36. Song J, Sapi E, Brown W, Nilsen J, Tartaro K, Kacinski BM, Craft J, Naftolin F and Mor G. (2000). J. Clin. Invest., 106, 1209-1220.
37. Song RX, Mor G, Naftolin F, McPherson RA, Song J, Zhang Z, Yue W, Wang J and Santen RJ. (2001). J. Natl. Cancer. Inst., 93, 1714-1723.
38. Suhara T, Mano T, Oliveira BE and Walsh K. (2001). Circ. Res., 89, 13-19.
39. Tilly JL. (1996). Rev. Reprod., 1, 162-172.
40. Tilly JL. (2001). Nat. Rev. Mol. Cell. Biol., 2, 838-848.
41. Weber G, Shen DF, Li W, Yang H, Look KY, Abonyi M and Prajda N. (2000). Eur. J. Gynaecol. Oncol., 21, 231-236.
42. Xerri L, Devilard E, Hassoun J, Mawas C and Birg F. (1997). Mol. Pathol., 50, 87-91.